DK169543B1 - 4-aryl-1-nikotinoylpiperazinderivater, fremgangsmåde til deres fremstilling og deres anvendelse i og til fremstilling af terapeutiske præparater - Google Patents

4-aryl-1-nikotinoylpiperazinderivater, fremgangsmåde til deres fremstilling og deres anvendelse i og til fremstilling af terapeutiske præparater Download PDF

Info

Publication number
DK169543B1
DK169543B1 DK684888A DK684888A DK169543B1 DK 169543 B1 DK169543 B1 DK 169543B1 DK 684888 A DK684888 A DK 684888A DK 684888 A DK684888 A DK 684888A DK 169543 B1 DK169543 B1 DK 169543B1
Authority
DK
Denmark
Prior art keywords
nicotinoylpiperazine
addition salts
preparation
formula
compound according
Prior art date
Application number
DK684888A
Other languages
Danish (da)
English (en)
Other versions
DK684888D0 (da
DK684888A (da
Inventor
Bernard Danree
Michelle Faulques
Jean-Yves Lacolle
Jean-Pierre Riffaud
Original Assignee
Inst Rech Chim Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Rech Chim Biolog filed Critical Inst Rech Chim Biolog
Publication of DK684888D0 publication Critical patent/DK684888D0/da
Publication of DK684888A publication Critical patent/DK684888A/da
Application granted granted Critical
Publication of DK169543B1 publication Critical patent/DK169543B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK684888A 1987-12-16 1988-12-08 4-aryl-1-nikotinoylpiperazinderivater, fremgangsmåde til deres fremstilling og deres anvendelse i og til fremstilling af terapeutiske præparater DK169543B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8717563 1987-12-16
FR8717563A FR2624857B1 (fr) 1987-12-16 1987-12-16 Derives de nicotinoyl-piperazine, procede de preparation et utilisation en therapeutique

Publications (3)

Publication Number Publication Date
DK684888D0 DK684888D0 (da) 1988-12-08
DK684888A DK684888A (da) 1989-06-17
DK169543B1 true DK169543B1 (da) 1994-11-28

Family

ID=9357932

Family Applications (1)

Application Number Title Priority Date Filing Date
DK684888A DK169543B1 (da) 1987-12-16 1988-12-08 4-aryl-1-nikotinoylpiperazinderivater, fremgangsmåde til deres fremstilling og deres anvendelse i og til fremstilling af terapeutiske præparater

Country Status (11)

Country Link
US (1) US4880807A (de)
EP (1) EP0323303B1 (de)
JP (1) JPH01199947A (de)
AT (1) ATE79374T1 (de)
CA (1) CA1316926C (de)
DE (1) DE3873720T2 (de)
DK (1) DK169543B1 (de)
ES (1) ES2043873T3 (de)
FR (1) FR2624857B1 (de)
GR (1) GR3006202T3 (de)
PT (1) PT89216B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016513112A (ja) * 2013-02-18 2016-05-12 ザ スクリプス リサーチ インスティテュート 治療的潜在能力を有するバソプレッシン受容体のモジュレーター

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE540697C (de) * 1925-08-11 1933-01-28 Chemische Ind Ges Verfahren zur Darstellung einseitig acylierter Diamine
BE795518A (fr) * 1972-02-17 1973-08-16 Ciba Geigy Nouveaux composes pyridiniques et leurs procedes de preparation
US3865828A (en) * 1972-03-22 1975-02-11 Egyt Gyogyszervegyeszeti Gyar Pyridine derivatives having antidepressant activity
CH653021A5 (fr) * 1981-04-24 1985-12-13 Delalande Sa Derives piperidino, piperazino et homopiperazino, n-substitues par un groupe heterocyclique aromatique, leur procede de preparation et composition therapeutique les contenant.
DE3601397A1 (de) * 1986-01-18 1987-07-23 Bayer Ag Substituierte 1,4-dihydropyridin-3-carbonsaeurepiperazide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
DE3873720D1 (de) 1992-09-17
EP0323303A1 (de) 1989-07-05
ES2043873T3 (es) 1994-01-01
ATE79374T1 (de) 1992-08-15
DK684888D0 (da) 1988-12-08
EP0323303B1 (de) 1992-08-12
JPH01199947A (ja) 1989-08-11
FR2624857A1 (fr) 1989-06-23
US4880807A (en) 1989-11-14
CA1316926C (en) 1993-04-27
DK684888A (da) 1989-06-17
PT89216A (pt) 1989-12-29
DE3873720T2 (de) 1993-03-11
GR3006202T3 (de) 1993-06-21
FR2624857B1 (fr) 1991-03-22
PT89216B (pt) 1993-07-30

Similar Documents

Publication Publication Date Title
FI83515B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 1-heteroaryl-4-/2,5-pyrrolidindion-1-yl) alkyl/ piperazinderivat.
JPH06293753A (ja) 2−〔4−〔(4,4−ジアルキル−2、6−ピペリジン ジオン−1−イル)ブチル〕−1−ピペラジニル〕ピリミジン含有組成物
IL27284A (en) AzaspiroDecondions and AzaspiroandCondions, a process for their preparation and pharmaceutical mixtures containing them
WO2021076902A1 (en) INHIBITING HUMAN INTEGRIN α 4 β 7
CA2883513A1 (en) Process for making thienopyrimidine compounds
AU2012229859C1 (en) Nitrogen-containing saturated heterocyclic compound
US2541211A (en) Tertiary-aminoalkyl-tetrahydrocarbazoles
Shao et al. Mild gold-catalyzed aerobic dehydrogenative coupling of amines and phenylglyoxal derivatives
Barát et al. Synthesis of (−)-cytisine using a 6-endo aza-Michael addition
Cannon et al. Centrally acting emetics. 10. Rigid dopamine congeners derived from octahydrobenzo [f] quinoline
HUT58045A (en) Process for producing new butinylamine derivatives and pharmaceutical compositions comprising such compounds
Miyano et al. New antiarrhythmic agents. N-aryl-8-pyrrolizidinealkanamides
EP2701504B1 (de) Sulindac-derivate, ihre verwendung und herstellung
DK169543B1 (da) 4-aryl-1-nikotinoylpiperazinderivater, fremgangsmåde til deres fremstilling og deres anvendelse i og til fremstilling af terapeutiske præparater
JP5260627B2 (ja) ベンゾフェノン化合物及びその作製方法
Schultz et al. Synthesis of chiral dibenzo-1, 8-diaza-14-crown-4, dibenzo-1, 9-diaza-16-crown-4, and dibenzo-1, 10-diaza-18-crown-4 ethers by aromatic nucleophilic substitution. Application to the preparation of bicyclic chiral crown-lithium iodide complexes
Boisse et al. From dicarbonylallene to 1-aryl-3, 6-dimethyl-4-aminoaryl-2-pyridones: a one-pot versatile and uncatalyzed synthesis
Katritzky et al. General synthesis of unsymmetrical tetrasubstituted oxamides via 1, 1′-(1, 2-dioxoethane-1, 2-diyl) bis-1H-benzotriazole
Mishra et al. Pd catalyzed N1/N4 arylation of piperazine for synthesis of drugs, biological and pharmaceutical targets: An overview of buchwald hartwig amination reaction of piperazine in drug synthesis
WO2016203054A1 (en) 15-substituted-derivatives of securinine useful in the treatment of cancer
Viault et al. The first synthesis of 2-amino-1, 4-dihydroquinolines
FI69627B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1-(3-(3,4,5-trimetoxifenoxi)-2-hydroxipropy)-4-aryl-piperazin-derivat
PL81191B1 (de)
US3153093A (en) Amino derivatives of nu-cyclopropylbenzylamines
Katritzky et al. Preparation, characterization and reactions of novel vicinal dibenzotriazol‐1‐yl derivatives of benzotriazole and glyoxal

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed